215 related articles for article (PubMed ID: 9235663)
1. [The endoscopic assessment of the effect of ranitidine and pirenzepine on the manifestations of the gastropathy induced by nonsteroidal anti-inflammatory preparations].
Karateev AE; Murav'ev IuV; Nasonova VA
Ter Arkh; 1997; 69(5):67-9. PubMed ID: 9235663
[TBL] [Abstract][Full Text] [Related]
2. [Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
Vakhrushev IaM; Loshchakova OIu
Eksp Klin Gastroenterol; 2007; (1):60-3, 71. PubMed ID: 17547116
[TBL] [Abstract][Full Text] [Related]
3. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
Yeomans ND
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfate.
Lazzaroni M; Sainaghi M; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S48-53. PubMed ID: 10379470
[TBL] [Abstract][Full Text] [Related]
5. The management of upper gastrointestinal problems in patients taking NSAIDs.
Prichard P
Aust Fam Physician; 1991 Dec; 20(12):1739-41. PubMed ID: 1687198
[TBL] [Abstract][Full Text] [Related]
6. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
Lazzaroni M; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
[TBL] [Abstract][Full Text] [Related]
8. [Ranitidine in the treatment of non-steroidal anti-inflammatory agent-induced damage of the stomach and duodenal mucosa. Results of a randomized, placebo-controlled double-blind study in patients with rheumatic diseases].
Simon B; Beckers KH; Biewer W; Bouzo MH; Dammann HG; Gebest HJ; Müller P; Schütz E
Z Gastroenterol; 1988 Jun; 26(6):310-3. PubMed ID: 3061183
[TBL] [Abstract][Full Text] [Related]
9. Addition of misoprostol to ranitidine in non-responders to H2-blockers and pirenzepine.
Walker S; Sarem-Aslani A; Treiber G; Klotz U; Bode JC
Neth J Med; 1991 Feb; 38(1-2):18-23. PubMed ID: 1674363
[TBL] [Abstract][Full Text] [Related]
10. Therapy of NSAIDs-induced gastropathy.
La Corte R; Caselli M; Ruina M; Bajocchi G; Alvisi V; Trotta F
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():37-41. PubMed ID: 9032582
[TBL] [Abstract][Full Text] [Related]
11. [Recurrence of gastropathies caused by intake of nonsteroidal anti-inflammatory drugs].
Karameev AE
Ter Arkh; 2003; 75(5):74-8. PubMed ID: 12847904
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial].
Karateev AE; Nasonov EL; Radenska-Lopovok SG
Ter Arkh; 2005; 77(2):46-9. PubMed ID: 15807452
[TBL] [Abstract][Full Text] [Related]
13. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
Chan FK; Sung JJ
N Engl J Med; 1998 Jul; 339(5):349-50; author reply 350-1. PubMed ID: 9696650
[No Abstract] [Full Text] [Related]
14. [The assessment of the effect of glucocorticosteroid and nonsteroidal anti-inflammatory preparations on the development of an erosive-ulcerative lesion of the gastrointestinal tract in patients with rheumatic diseases].
Karateev AE; Nasonova VA; Murav'ev IuV
Ter Arkh; 1999; 71(2):26-30. PubMed ID: 10222549
[TBL] [Abstract][Full Text] [Related]
15. Does famotidine have similar efficacy to misoprostol in the treatment of non-steroidal anti-inflammatory drug-induced gastropathy?
Wu CS; Wang SH; Chen PC; Wu VC
Int J Clin Pract; 1998 Oct; 52(7):472-4. PubMed ID: 10622088
[TBL] [Abstract][Full Text] [Related]
16. Misoprostol and NSAID ulcers.
Isaacs P
Am J Gastroenterol; 1996 Feb; 91(2):187-8. PubMed ID: 8607480
[No Abstract] [Full Text] [Related]
17. [The use of misoprostol in prevention of gastric disease from nonsteroidal anti-inflammatory drugs in oral-maxillofacial surgery].
Bocca M; Giordano M; Del Pizzo M; Nelken A; Ghiggia M; Pomatto E
Minerva Ortognatod; 1990; 8(2):139-41. PubMed ID: 2126183
[TBL] [Abstract][Full Text] [Related]
18. Ranitidine effect on gastric mucosa damage in patients with rheumatoid diseases on long-term treatment with non-steroid anti-inflammatory drugs.
Piotrowski J; Gabryelewicz A; Konturek S; Kwiecień N; Rydzewska G; Sierakowski S; Zimnoch L
Mater Med Pol; 1986; 18(3):170-6. PubMed ID: 3807434
[No Abstract] [Full Text] [Related]
19. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy.
Scheiman JM
Am J Manag Care; 2001 Feb; 7(1 Suppl):S10-4. PubMed ID: 11225347
[TBL] [Abstract][Full Text] [Related]
20. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
